The Nervous System Study

The Nervous System Study aims to evaluate the safety and tolerability of a new investigational treatment for Friedreich’s Ataxia in healthy volunteers. Your participation will help us gather crucial data to advance our research and move closer to a potential treatment for FA.

Friedreich’s ataxia (FA) is a rare genetic disease that typically begins in childhood, between the ages of 5 and 15. It affects movement, speech, and daily activities. Over time, FA can lead to a loss of mobility and other serious health issues such as heart problems and diabetes, often shortening life expectancy to the 30s or 40s.

Clinical Trial Details:

• This is the first time the study drug is being administered to humans, so there may be unknown risks involved. However, this clinical trial has been carefully designed to minimize risks for participants. Before you decide to participate, you will receive detailed information about the trial, including its risks and our mitigation strategies. You will also have an appointment with one of our doctors, who will be happy to answer any questions you may have.
• An independent ethics committee has approved this clinical trial.

Call us on 1800 243 733 to discuss your eligibility today!